MeMed Ltd., a leader in host response-based diagnostic solutions, today announced that it has received €2.5 million in non-dilutive funding from the European Innovation Council (EIC).
Israeli diagnostics player MeMed reported data from a study of more than 500 children and adolescents showing that its blood test can accurately tell the difference between a bacterial and a viral infection.